IBRX

3.36

20.86% 0.58

Pre-mercato: 3.50 0.14 +4.17%

Immunitybio Inc (IBRX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché IBRX Giù? Forum Previsione

Precedente Chiudi:

$2.78

Aprire:

$2.78

Volume 24 ore:

16.36M

Relative Volume:

2.80

Capitalizzazione di mercato:

$2.87B

Reddito:

$1.31M

Utile/perdita netta:

$-597.65M

Rapporto P/E:

-3.4639

EPS:

-0.97

Flusso di cassa netto:

$-425.62M

1 W Prestazione:

+22.18%

1M Prestazione:

+17.48%

6M Prestazione:

-14.50%

1 anno Prestazione:

-38.46%

Intervallo 1D:

$2.78

$3.375

Intervallo di 1 settimana:

$2.68

$3.375

Portata 52W:

$2.28

$10.53

Immunitybio Inc Stock (IBRX) Company Profile

Nome

Immunitybio Inc

Settore

Healthcare (1167)

Industria

Biotechnology (681)

Telefono

(844) 696-5235

Indirizzo

3530 JOHN HOPKINS COURT, SAN DIEGO

Dipendente

680

Cinguettio

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

IBRX's Discussions on Twitter

Confronta IBRX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
IBRX Immunitybio Inc	3.36	2.87B	1.31M	-597.65M	-425.62M	-0.97
VRTX Vertex Pharmaceuticals Inc	502.55	131.41B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	635.83	72.26B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	593.47	36.20B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	271.02	35.08B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	262.60	28.24B	3.81B	-644.79M	-669.77M	-6.24

Immunitybio Inc Stock (IBRX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-03-06	Iniziato	H.C. Wainwright	Buy
2025-01-10	Iniziato	BTIG Research	Buy
2023-05-12	Downgrade	Piper Sandler	Overweight → Neutral
2022-08-03	Iniziato	Jefferies	Buy

Immunitybio Inc Borsa (IBRX) Ultime notizie

Mar 26, 2025

ImmunityBio to Host Investor Day - BioSpace

Mar 26, 2025

Mar 25, 2025

Is ImmunityBio, Inc. (NASDAQ:IBRX) The Top Penny Stock That Will Skyrocket? - Insider Monkey

Mar 25, 2025

Mar 24, 2025

Investor Alert: Wolfspeed, Driven Brands Holdings, Hasbro, - GlobeNewswire

Mar 24, 2025

Investor Alert: Wolfspeed, Driven Brands Holdings, Hasbro, and ImmunityBio: Johnson Fistel, PLLP Investigates - EIN News

Mar 24, 2025

Mar 19, 2025

ImmunityBio appoints Deloitte as new auditor By Investing.com - Investing.com South Africa

Mar 19, 2025

ImmunityBio appoints Deloitte as new auditor - Investing.com Australia

Mar 19, 2025

Mar 18, 2025

Drugmaker's $10.5M Deal In Investor FDA Approval Suit OK'd - Law360

Mar 18, 2025

ImmunityBio $10.5 Million Settlement Over Record Selloff Gets OK - Bloomberg Law

Mar 18, 2025

From cancer vaccines to COPD treatments, these 10 companies are developing innovative medicines - Fast Company

Mar 18, 2025

Mar 17, 2025

ImmunityBio ($IBRX) Is Paying a $10.5M Settlement to Investors — Here’s How to Get Your Share - TradingView

Mar 17, 2025

Mar 14, 2025

H.C. Wainwright maintains $8 target for ImmunityBio stock By Investing.com - Investing.com Australia

Mar 14, 2025

H.C. Wainwright maintains $8 target for ImmunityBio stock - Investing.com

Mar 14, 2025

Mar 13, 2025

Recombinant BCG Vaccine Becomes Available in the U.S. - Precision Vaccinations

Mar 13, 2025

ImmunityBio Announces First Dosing of Recombinant BCG (rBCG) in the U.S. and 60 Sites Are in the Process of Launching - BioSpace

Mar 13, 2025

ImmunityBio Partner US Urology Begins Administering rBCG to Address Tice BCG Shortage - Marketscreener.com

Mar 13, 2025

Mar 12, 2025